Get started
Author

Jane E. Cluderay

Observed names: J. E. Cluderay, J.E Cluderay, J.E. Cluderay, Jane Cluderay, Jane E Cluderay
Observed institution: GlaxoSmithKline (United Kingdom)
OpenAlex ID: A5050697644
Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1
1999 · Jon Chambers, Robert S. Ames, et al. · Nature · 494
Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord
2001 · G.J Hervieu, J.E Cluderay, et al. · Neuroscience · 466
The distribution of the mRNA and protein products of the melanin‐concentrating hormone (MCH) receptor gene, slc‐1, in the central nervous system of the rat
2000 · G. J. Hervieu, J. E. Cluderay, et al. · European Journal of Neuroscience · 310
GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models
2007 · Andrew D. Medhurst, Alan R. Atkins, et al. · Journal of Pharmacology and Experimental Therapeutics · 299
Protein distribution of the orexin-2 receptor in the rat central nervous system
2002 · J.E Cluderay, D.C Harrison, et al. · Regulatory Peptides · 267
Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS
2001 · G.J Hervieu, J.E Cluderay, et al. · Neuroscience · 180
LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease
2003 · S.M Harrison, C Reavill, et al. · Molecular and Cellular Neuroscience · 129
Expression of Melanin-Concentrating Hormone Receptors in Insulin-Producing Cells: MCH Stimulates Insulin Release in RINm5F and CRI-G1 Cell-Lines
2000 · M. Tadayyon, H.J. Welters, et al. · Biochemical and Biophysical Research Communications · 60
Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040
2008 · Eric Southam, Jackie Cilia, et al. · Psychopharmacology · 54
Reversal of isolation-rearing-induced PPI deficits by an α7 nicotinic receptor agonist
2005 · Jackie Cilia, Jane E. Cluderay, et al. · Psychopharmacology · 53
Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation
2009 · Julia J. Turnock‐Jones, Carol A. Jennings, et al. · Synapse · 50
In Vitro and In Vivo Characterization of the Non-peptide NK3 Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the Treatment of Schizophrenia
2007 · Lee A Dawson, Katherine J Cato, et al. · Neuropsychopharmacology · 45
Effect of the selective dopamine D3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain
2007 · Eric Southam, Andrew Lloyd, et al. · Brain Research · 15
The effects of ziprasidone on regional c-Fos expression in the rat forebrain
2005 · C. A. Jennings, J. E. Cluderay, et al. · Psychopharmacology · 14
In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics
2009 · Lee A. Dawson, Christopher J. Langmead, et al. · European Journal of Pharmacology · 13
Chapter II The melanin-concentrating hormone
2002 · Guillaume J. Hervieu, Laurence Maulon-Feraille, et al. · Handbook of chemical neuroanatomy · 4
Effect of the selective dopamine D3 receptor antagonist SB-277011 on regional fos expression in the rat forebrain
2003 · E. Southam, C.A. Jennings, et al. · Schizophrenia Research · 3
P.2.019 The effects expression regional c-Fosprotein expression in the rat forebrain
2004 · J.E. Cluderay, S.L. Simonini, et al. · European Neuropsychopharmacology
Comparison of the effects of ziprasidone and haloperidol on regional fos expression in rat forebrain
2003 · C.A. Jennings, E. Southam, et al. · Schizophrenia Research
Works count: 19
Citation count: 2,456
H-index: 14
I10-index: 15
Year
Topic
Type